post-traumatic stress disorder
| 3 min read
An FDA advisory panel voted against recommending the psychedelic MDMA for PTSD, puncturing excitement around the drug’s potential.
| 3 min read
The properties of a little-known psychedelic drug may be perfectly tailored to relieve the psychiatric and cognitive symptoms of the disease.
| 10 min read
Researchers explore the role of forgetting in normal brain function and as a therapeutic target for fear-related disorders.
Page 1 of 1 - 3 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
Subscribe